Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lewis Meecham

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Journal of Vascular Surgery|September 5, 2021
Procedural and 12-month in-hospital costs of primary infra-popliteal bypass surgery, infrapopliteal best endovascular treatment, and major lower limb amputation for chronic limb threatening ischemiaMatthew A Popplewell, Lazaros Andronis, Huw O B Davies, et al.
The Journal of Vascular Access|November 4, 2014
Vascular access in the obese: superficialisation of native radio-cephalic and brachio-cephalic fistulaeRichard P T Evans, Lewis Meecham, Pauline Buxton, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|September 7, 2017
Outcome after Turndown for Elective Abdominal Aortic Aneurysm SurgeryJoshua D Whittaker, Lewis Meecham, Virginia Summerour, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|October 1, 2023
Editor's Choice - Bypass versus Angioplasty for Severe Ischaemia of the Leg (BASIL) Prospective Cohort Study and the Generalisability of the BASIL-2 Randomised Controlled TrialMatthew A Popplewell, Lewis Meecham, Huw O B Davies, et al.
BMJ (Clinical Research Ed.)|February 24, 2025
Plain versus drug balloon and stenting in severe ischaemia of the leg (BASIL-3): open label, three arm, randomised, multicentre, phase 3 trialAndrew W Bradbury, Jack A Hall, Matthew A Popplewell, et al.
The British Journal of Surgery|June 28, 2025
A vein bypass first versus a best endovascular treatment first revascularization strategy for patients with chronic limb-threatening ischaemia who require an infra-popliteal, with or without an additional more proximal infra-inguinal, revascularization procedure to restore limb perfusion: the BASIL-2 within-trial health economic analysisZainab Abdali, Jesse Kigozi, Catherine A Moakes, et al.
BMJ Open|December 31, 2025
CORE-ALI: protocol for a pan-European mixed-methods study to develop a core outcome set for acute lower limb ischaemiaMaram Darwish, Lewis Meecham, Leszek Kukulski, et al.
The British Journal of Surgery|March 4, 2026
Plain balloon angioplasty with or without bare-metal stenting versus drug-coated balloon angioplasty with or without bare-metal stenting versus primary drug-eluting stenting in patients requiring femoropopliteal, with or without infrapopliteal, endovascular revascularization for chronic limb-threatening ischaemia: BASIL-3 within-trial health economic analysisMishal Javed, Jesse Kigozi, Catherine A Moakes, et al.
Health Technology Assessment (Winchester, England)|July 1, 2026
Plain balloon angioplasty +/- bare metal stenting versus drug-coated balloon angioplasty +/- bare metal stenting versus primary drug-eluting stenting in patients with chronic limb-threatening ischaemia: BASIL-3, an open-label, three-arm, randomised, multi-centre, phase 3 trialMatthew A Popplewell, Jack A Hall, Jesse Kigozi, et al.
Trials|May 21, 2017
BAlloon versus Stenting in severe Ischaemia of the Leg-3 (BASIL-3): study protocol for a randomised controlled trialBenjamin D Hunt, Matthew A Popplewell, Huw Davies, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Journal of Vascular Surgery|September 5, 2021
Procedural and 12-month in-hospital costs of primary infra-popliteal bypass surgery, infrapopliteal best endovascular treatment, and major lower limb amputation for chronic limb threatening ischemiaMatthew A Popplewell, Lazaros Andronis, Huw O B Davies, et al.
The Journal of Vascular Access|November 4, 2014
Vascular access in the obese: superficialisation of native radio-cephalic and brachio-cephalic fistulaeRichard P T Evans, Lewis Meecham, Pauline Buxton, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|September 7, 2017
Outcome after Turndown for Elective Abdominal Aortic Aneurysm SurgeryJoshua D Whittaker, Lewis Meecham, Virginia Summerour, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|October 1, 2023
Editor's Choice - Bypass versus Angioplasty for Severe Ischaemia of the Leg (BASIL) Prospective Cohort Study and the Generalisability of the BASIL-2 Randomised Controlled TrialMatthew A Popplewell, Lewis Meecham, Huw O B Davies, et al.
BMJ (Clinical Research Ed.)|February 24, 2025
Plain versus drug balloon and stenting in severe ischaemia of the leg (BASIL-3): open label, three arm, randomised, multicentre, phase 3 trialAndrew W Bradbury, Jack A Hall, Matthew A Popplewell, et al.
The British Journal of Surgery|June 28, 2025
A vein bypass first versus a best endovascular treatment first revascularization strategy for patients with chronic limb-threatening ischaemia who require an infra-popliteal, with or without an additional more proximal infra-inguinal, revascularization procedure to restore limb perfusion: the BASIL-2 within-trial health economic analysisZainab Abdali, Jesse Kigozi, Catherine A Moakes, et al.
BMJ Open|December 31, 2025
CORE-ALI: protocol for a pan-European mixed-methods study to develop a core outcome set for acute lower limb ischaemiaMaram Darwish, Lewis Meecham, Leszek Kukulski, et al.
The British Journal of Surgery|March 4, 2026
Plain balloon angioplasty with or without bare-metal stenting versus drug-coated balloon angioplasty with or without bare-metal stenting versus primary drug-eluting stenting in patients requiring femoropopliteal, with or without infrapopliteal, endovascular revascularization for chronic limb-threatening ischaemia: BASIL-3 within-trial health economic analysisMishal Javed, Jesse Kigozi, Catherine A Moakes, et al.
Health Technology Assessment (Winchester, England)|July 1, 2026
Plain balloon angioplasty +/- bare metal stenting versus drug-coated balloon angioplasty +/- bare metal stenting versus primary drug-eluting stenting in patients with chronic limb-threatening ischaemia: BASIL-3, an open-label, three-arm, randomised, multi-centre, phase 3 trialMatthew A Popplewell, Jack A Hall, Jesse Kigozi, et al.
Trials|May 21, 2017
BAlloon versus Stenting in severe Ischaemia of the Leg-3 (BASIL-3): study protocol for a randomised controlled trialBenjamin D Hunt, Matthew A Popplewell, Huw Davies, et al.
Pageof 4